Dr. Jason M. Rizzo, MD

Dr. Rizzo practices at The Woodruff Institute in Naples, Florida.

Dr. Rizzo's NPI, 1124446554, was assigned on April 2, 2014. Dr. Rizzo graduated from Jacobs School of Medicine and Biomedical Sciences in 2014. Dr. Rizzo's New York license number on file is 296429-1.

Dr. Rizzo's primary practice is The Woodruff Institute, at 2235 Venetian Ct, Naples, FL 34109 in Collier County. The practice phone is (239) 596-9337.

Dr. Rizzo's primary practice is The Woodruff Institute in Naples, Florida. The medical group on file is The Woodruff Institute for Dermatology & Cosmetic Surgery. Dmand AI also links Dr. Rizzo to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizzo practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Rizzo's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Rizzo is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Rizzo's licenses on file in 3 states: New York, Florida and Michigan.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, joint cyst, minor injury to a limb and psoriasis among the conditions Dr. Rizzo treats.

CMS data shows 3,900 Medicare services from Dr. Rizzo across 31 procedure codes in 2024, for 783 Medicare patients. Medicare paid $689,100 for them. Every service was in an office.

CMS counts 783 Medicare patients who saw Dr. Rizzo in 2024. The largest group is 75 to 84, with 414 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rizzo's median patient age at 78, with 41% women.

In 2024, Dr. Rizzo wrote 961 Medicare Part D claims for 609 patients. 95% of them were for generic drugs. CMS names the drug for 891 of them, across 8 drugs with 11 or more claims each, at $29,824 in total drug cost. In 2023, CMS named 871 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rizzo for performance year 2024, reported as part of a group. Dr. Rizzo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 114 procedures of melanoma (skin cancer) excision by Dr. Rizzo, more than 94% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Rizzo, published from 2011 to 2024. 2011 was the busiest year, with 5. The most frequent topics are Saccharomyces cerevisiae, Micrococcal Nuclease and Chromatin. Dr. Rizzo has published most often in JAAD Case Rep. Dr. Rizzo's most frequent co-authors are Alison B. Durham, MD, Ilene L. Rothman, MD and Matthew Ryan Clark, MD.

CMS Open Payments shows 212 general payments to Dr. Rizzo from 22 drug and device companies from 2019 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 46% of the total. Kerecis Limited paid the most, $50,633.

Dr. Rizzo graduated from Jacobs School of Medicine and Biomedical Sciences in 2014.

Dr. Rizzo is in network with 17 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.